| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lung Neoplasms | 31 | 2025 | 1541 | 3.090 |
Why?
|
| Genome-Wide Association Study | 23 | 2024 | 1839 | 2.860 |
Why?
|
| Polymorphism, Single Nucleotide | 31 | 2023 | 2862 | 2.820 |
Why?
|
| Genetic Predisposition to Disease | 28 | 2025 | 3411 | 2.000 |
Why?
|
| Melanoma | 9 | 2025 | 920 | 1.940 |
Why?
|
| Selection, Genetic | 6 | 2024 | 157 | 1.930 |
Why?
|
| Genome, Human | 15 | 2020 | 1332 | 1.660 |
Why?
|
| Skin Neoplasms | 7 | 2024 | 904 | 1.610 |
Why?
|
| Gene Expression Profiling | 14 | 2026 | 1831 | 1.520 |
Why?
|
| Mutation, Missense | 13 | 2024 | 929 | 1.490 |
Why?
|
| Prostatic Neoplasms | 11 | 2017 | 1417 | 1.450 |
Why?
|
| Codon, Nonsense | 3 | 2022 | 141 | 1.400 |
Why?
|
| Gene Expression Regulation, Neoplastic | 11 | 2025 | 1988 | 1.170 |
Why?
|
| Neoplasms | 7 | 2020 | 2969 | 1.040 |
Why?
|
| Neoplasm Proteins | 4 | 2018 | 676 | 1.030 |
Why?
|
| Genes, Neoplasm | 2 | 2019 | 80 | 0.940 |
Why?
|
| Gene Frequency | 6 | 2022 | 750 | 0.860 |
Why?
|
| Biomarkers, Tumor | 10 | 2025 | 1617 | 0.850 |
Why?
|
| Quantitative Trait Loci | 4 | 2022 | 307 | 0.730 |
Why?
|
| X Chromosome | 1 | 2023 | 331 | 0.730 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 7 | 2023 | 327 | 0.720 |
Why?
|
| Computational Biology | 6 | 2015 | 872 | 0.690 |
Why?
|
| Scleroderma, Systemic | 2 | 2019 | 130 | 0.680 |
Why?
|
| Frameshift Mutation | 2 | 2019 | 202 | 0.670 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2026 | 403 | 0.670 |
Why?
|
| Biological Evolution | 5 | 2015 | 229 | 0.630 |
Why?
|
| Humans | 80 | 2026 | 131501 | 0.610 |
Why?
|
| Mutation | 8 | 2024 | 6176 | 0.600 |
Why?
|
| Genetic Variation | 6 | 2020 | 1556 | 0.590 |
Why?
|
| Germ-Line Mutation | 2 | 2020 | 372 | 0.590 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 5 | 2020 | 1008 | 0.510 |
Why?
|
| Models, Statistical | 3 | 2019 | 492 | 0.510 |
Why?
|
| RNA Splicing | 3 | 2014 | 234 | 0.480 |
Why?
|
| Blood | 1 | 2015 | 100 | 0.460 |
Why?
|
| Gene Expression | 2 | 2018 | 1500 | 0.450 |
Why?
|
| Genomics | 2 | 2014 | 1624 | 0.450 |
Why?
|
| Male | 54 | 2026 | 65158 | 0.450 |
Why?
|
| Exons | 4 | 2014 | 768 | 0.450 |
Why?
|
| Alleles | 5 | 2020 | 1708 | 0.440 |
Why?
|
| Genes, p53 | 2 | 2005 | 213 | 0.430 |
Why?
|
| Crossing Over, Genetic | 4 | 2001 | 53 | 0.430 |
Why?
|
| Carcinogenesis | 1 | 2017 | 356 | 0.420 |
Why?
|
| Logistic Models | 7 | 2022 | 1831 | 0.400 |
Why?
|
| Introns | 1 | 2014 | 287 | 0.390 |
Why?
|
| MicroRNAs | 3 | 2025 | 894 | 0.380 |
Why?
|
| Algorithms | 5 | 2016 | 1685 | 0.370 |
Why?
|
| Chromosomes, Human, Pair 15 | 4 | 2018 | 144 | 0.370 |
Why?
|
| Environmental Exposure | 1 | 2015 | 290 | 0.370 |
Why?
|
| Meiosis | 7 | 2001 | 112 | 0.370 |
Why?
|
| Recombination, Genetic | 4 | 2001 | 426 | 0.350 |
Why?
|
| Carcinoma, Squamous Cell | 4 | 2024 | 758 | 0.350 |
Why?
|
| Cryptorchidism | 4 | 2012 | 38 | 0.340 |
Why?
|
| CpG Islands | 4 | 2023 | 337 | 0.340 |
Why?
|
| Genotype | 14 | 2016 | 2655 | 0.340 |
Why?
|
| Case-Control Studies | 15 | 2024 | 3452 | 0.340 |
Why?
|
| Receptors, Nicotinic | 5 | 2012 | 132 | 0.340 |
Why?
|
| Lung | 4 | 2023 | 1565 | 0.340 |
Why?
|
| Evolution, Molecular | 1 | 2014 | 657 | 0.330 |
Why?
|
| Oncogenes | 2 | 2022 | 164 | 0.330 |
Why?
|
| Neoplasm Staging | 6 | 2025 | 1322 | 0.320 |
Why?
|
| Chromosomes, Human, Pair 5 | 3 | 2019 | 109 | 0.320 |
Why?
|
| Breast Neoplasms | 2 | 2019 | 2646 | 0.310 |
Why?
|
| Genes, Essential | 1 | 2009 | 43 | 0.310 |
Why?
|
| Genetics, Population | 3 | 2017 | 185 | 0.300 |
Why?
|
| Disease | 1 | 2010 | 125 | 0.300 |
Why?
|
| Databases, Nucleic Acid | 2 | 2008 | 73 | 0.300 |
Why?
|
| Membrane Proteins | 3 | 2019 | 1612 | 0.290 |
Why?
|
| Female | 36 | 2026 | 71086 | 0.290 |
Why?
|
| DNA Methylation | 3 | 2024 | 1085 | 0.290 |
Why?
|
| Chromosomes | 3 | 2000 | 117 | 0.270 |
Why?
|
| Carcinoma, Small Cell | 1 | 2007 | 39 | 0.270 |
Why?
|
| Organ Specificity | 2 | 2019 | 400 | 0.260 |
Why?
|
| Smoking | 8 | 2024 | 926 | 0.260 |
Why?
|
| Risk Factors | 17 | 2026 | 10952 | 0.250 |
Why?
|
| Adenocarcinoma | 6 | 2020 | 999 | 0.240 |
Why?
|
| Telomerase | 3 | 2019 | 157 | 0.240 |
Why?
|
| Homozygote | 4 | 2001 | 547 | 0.240 |
Why?
|
| Middle Aged | 24 | 2026 | 28839 | 0.240 |
Why?
|
| Gene Expression Regulation | 3 | 2026 | 2355 | 0.230 |
Why?
|
| Penetrance | 1 | 2025 | 116 | 0.230 |
Why?
|
| Survival Analysis | 2 | 2019 | 1521 | 0.220 |
Why?
|
| Disease Progression | 3 | 2026 | 2205 | 0.220 |
Why?
|
| Point Mutation | 1 | 2006 | 339 | 0.220 |
Why?
|
| Reproducibility of Results | 4 | 2022 | 2985 | 0.210 |
Why?
|
| Prognosis | 11 | 2025 | 4951 | 0.210 |
Why?
|
| Receptors, G-Protein-Coupled | 3 | 2010 | 300 | 0.210 |
Why?
|
| Regulatory Sequences, Ribonucleic Acid | 1 | 2003 | 14 | 0.210 |
Why?
|
| Nucleic Acids | 1 | 2023 | 26 | 0.200 |
Why?
|
| Heterozygote | 4 | 2020 | 728 | 0.190 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2004 | 274 | 0.190 |
Why?
|
| Odds Ratio | 3 | 2022 | 1235 | 0.190 |
Why?
|
| Sequence Analysis, RNA | 1 | 2025 | 420 | 0.190 |
Why?
|
| Homeodomain Proteins | 2 | 2002 | 568 | 0.190 |
Why?
|
| Receptors, Androgen | 3 | 2016 | 418 | 0.190 |
Why?
|
| Nucleotides | 1 | 2022 | 90 | 0.180 |
Why?
|
| DNA-Binding Proteins | 3 | 2022 | 1956 | 0.180 |
Why?
|
| Chromosome Mapping | 5 | 2012 | 1069 | 0.170 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 2 | 2020 | 100 | 0.170 |
Why?
|
| Conserved Sequence | 1 | 2022 | 281 | 0.170 |
Why?
|
| Nigella sativa | 1 | 2020 | 1 | 0.170 |
Why?
|
| Trigonella | 1 | 2020 | 2 | 0.170 |
Why?
|
| Receptors, Cell Surface | 2 | 2002 | 432 | 0.170 |
Why?
|
| Proteins | 3 | 2018 | 1025 | 0.170 |
Why?
|
| Dehydroepiandrosterone Sulfate | 1 | 2020 | 22 | 0.170 |
Why?
|
| Silent Mutation | 1 | 2020 | 3 | 0.170 |
Why?
|
| Chromosome Inversion | 2 | 1991 | 73 | 0.160 |
Why?
|
| Open Reading Frames | 2 | 2014 | 200 | 0.160 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2003 | 600 | 0.160 |
Why?
|
| Aged | 17 | 2025 | 21238 | 0.160 |
Why?
|
| Regulatory Elements, Transcriptional | 1 | 2019 | 30 | 0.160 |
Why?
|
| Ultraviolet Rays | 1 | 2020 | 195 | 0.150 |
Why?
|
| Genetic Association Studies | 2 | 2022 | 837 | 0.150 |
Why?
|
| Promoter Regions, Genetic | 1 | 2023 | 1217 | 0.150 |
Why?
|
| Phylogeny | 2 | 2018 | 707 | 0.150 |
Why?
|
| Mammals | 1 | 2000 | 258 | 0.150 |
Why?
|
| Principal Component Analysis | 2 | 2017 | 153 | 0.150 |
Why?
|
| Simuliidae | 1 | 2018 | 4 | 0.150 |
Why?
|
| Mucins | 1 | 2019 | 69 | 0.150 |
Why?
|
| Polytene Chromosomes | 1 | 2018 | 3 | 0.150 |
Why?
|
| Karyotype | 1 | 2018 | 29 | 0.140 |
Why?
|
| Transcriptome | 1 | 2025 | 1162 | 0.140 |
Why?
|
| Mutation Rate | 1 | 2018 | 68 | 0.140 |
Why?
|
| Risk | 1 | 2020 | 739 | 0.140 |
Why?
|
| Liver | 1 | 2026 | 1795 | 0.140 |
Why?
|
| Multivariate Analysis | 1 | 2022 | 1404 | 0.140 |
Why?
|
| Loss of Function Mutation | 1 | 2019 | 160 | 0.140 |
Why?
|
| G1 Phase Cell Cycle Checkpoints | 1 | 2017 | 16 | 0.130 |
Why?
|
| Leukocytes | 1 | 2018 | 211 | 0.130 |
Why?
|
| Autoimmunity | 1 | 2018 | 181 | 0.130 |
Why?
|
| Linkage Disequilibrium | 3 | 2012 | 318 | 0.130 |
Why?
|
| Linear Models | 1 | 2019 | 695 | 0.130 |
Why?
|
| Adult | 10 | 2026 | 31666 | 0.130 |
Why?
|
| Testis | 3 | 2012 | 413 | 0.130 |
Why?
|
| Karyotyping | 6 | 2000 | 314 | 0.120 |
Why?
|
| Finasteride | 1 | 2016 | 16 | 0.120 |
Why?
|
| Mice | 12 | 2012 | 18470 | 0.120 |
Why?
|
| Cell Cycle Proteins | 2 | 2012 | 703 | 0.120 |
Why?
|
| Computer Simulation | 2 | 2014 | 685 | 0.120 |
Why?
|
| Phenotype | 7 | 2018 | 4515 | 0.120 |
Why?
|
| Microbiota | 1 | 2020 | 441 | 0.110 |
Why?
|
| Models, Genetic | 4 | 2008 | 751 | 0.110 |
Why?
|
| Prostatectomy | 1 | 2016 | 313 | 0.110 |
Why?
|
| Small Cell Lung Carcinoma | 2 | 2012 | 32 | 0.110 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2022 | 833 | 0.110 |
Why?
|
| Animals | 17 | 2022 | 34335 | 0.110 |
Why?
|
| Inflammation | 2 | 2012 | 1490 | 0.110 |
Why?
|
| Colonic Neoplasms | 1 | 2017 | 265 | 0.110 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 2 | 2018 | 651 | 0.100 |
Why?
|
| Alternative Splicing | 2 | 2007 | 313 | 0.100 |
Why?
|
| Interleukin-2 Receptor beta Subunit | 1 | 2012 | 5 | 0.090 |
Why?
|
| DNA Transposable Elements | 1 | 1993 | 182 | 0.090 |
Why?
|
| Life Style | 1 | 2015 | 444 | 0.090 |
Why?
|
| Decision Support Techniques | 1 | 2015 | 297 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 6 | 1 | 2012 | 139 | 0.090 |
Why?
|
| Precision Medicine | 1 | 2015 | 376 | 0.090 |
Why?
|
| Cocarcinogenesis | 1 | 2011 | 15 | 0.090 |
Why?
|
| Robotic Surgical Procedures | 1 | 2016 | 235 | 0.090 |
Why?
|
| Animal Feed | 2 | 2022 | 76 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2012 | 173 | 0.090 |
Why?
|
| Chickens | 2 | 2022 | 286 | 0.090 |
Why?
|
| Cluster Analysis | 1 | 2012 | 418 | 0.080 |
Why?
|
| Ligaments | 1 | 2010 | 20 | 0.080 |
Why?
|
| Software | 1 | 2016 | 752 | 0.080 |
Why?
|
| Proto-Oncogene Proteins B-raf | 2 | 2023 | 220 | 0.080 |
Why?
|
| Laparoscopy | 1 | 2016 | 525 | 0.080 |
Why?
|
| Tobacco Smoke Pollution | 1 | 2011 | 93 | 0.080 |
Why?
|
| Cardiovascular Diseases | 2 | 2020 | 2081 | 0.080 |
Why?
|
| Liver Cirrhosis, Biliary | 1 | 2010 | 90 | 0.080 |
Why?
|
| Mice, Transgenic | 3 | 2012 | 2363 | 0.080 |
Why?
|
| Genotyping Techniques | 2 | 2020 | 110 | 0.080 |
Why?
|
| beta Catenin | 1 | 2010 | 209 | 0.080 |
Why?
|
| Nerve Tissue Proteins | 3 | 2012 | 1122 | 0.070 |
Why?
|
| Receptors, Notch | 1 | 2010 | 204 | 0.070 |
Why?
|
| Genes, Overlapping | 1 | 2008 | 7 | 0.070 |
Why?
|
| Survival Rate | 2 | 2012 | 2149 | 0.070 |
Why?
|
| 5' Untranslated Regions | 1 | 2008 | 57 | 0.070 |
Why?
|
| Neoplasm Metastasis | 1 | 2010 | 711 | 0.070 |
Why?
|
| 3' Untranslated Regions | 1 | 2008 | 164 | 0.070 |
Why?
|
| Europe | 2 | 2019 | 372 | 0.070 |
Why?
|
| Aged, 80 and over | 5 | 2024 | 6916 | 0.070 |
Why?
|
| Sex Factors | 1 | 2011 | 1345 | 0.070 |
Why?
|
| Signal Transduction | 3 | 2012 | 4674 | 0.060 |
Why?
|
| Predictive Value of Tests | 1 | 2012 | 2297 | 0.060 |
Why?
|
| Diet | 3 | 2022 | 1119 | 0.060 |
Why?
|
| Spermatocytes | 1 | 1986 | 23 | 0.060 |
Why?
|
| Colorectal Neoplasms | 1 | 2012 | 638 | 0.060 |
Why?
|
| DNA, Recombinant | 1 | 2006 | 71 | 0.060 |
Why?
|
| PAX6 Transcription Factor | 2 | 2002 | 37 | 0.060 |
Why?
|
| Bone Neoplasms | 1 | 2010 | 444 | 0.060 |
Why?
|
| Paired Box Transcription Factors | 2 | 2002 | 75 | 0.060 |
Why?
|
| Insulin | 1 | 2010 | 1145 | 0.060 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2002 | 1236 | 0.060 |
Why?
|
| Polymorphism, Genetic | 2 | 2007 | 794 | 0.060 |
Why?
|
| Sensitivity and Specificity | 1 | 2010 | 2143 | 0.060 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2007 | 489 | 0.060 |
Why?
|
| Protein Isoforms | 2 | 2002 | 420 | 0.050 |
Why?
|
| Data Interpretation, Statistical | 1 | 2005 | 227 | 0.050 |
Why?
|
| Genetic Markers | 3 | 1993 | 605 | 0.050 |
Why?
|
| 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase | 1 | 2004 | 19 | 0.050 |
Why?
|
| Eye Proteins | 2 | 2002 | 234 | 0.050 |
Why?
|
| Chromosome Aberrations | 2 | 2023 | 577 | 0.050 |
Why?
|
| Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2004 | 64 | 0.050 |
Why?
|
| Smokers | 1 | 2024 | 44 | 0.050 |
Why?
|
| Postoperative Complications | 1 | 2016 | 3113 | 0.050 |
Why?
|
| ROC Curve | 1 | 2025 | 615 | 0.050 |
Why?
|
| MutS Homolog 2 Protein | 1 | 2003 | 39 | 0.050 |
Why?
|
| MutL Protein Homolog 1 | 1 | 2003 | 52 | 0.050 |
Why?
|
| Haplotypes | 3 | 2011 | 543 | 0.050 |
Why?
|
| Molecular Sequence Data | 3 | 2002 | 3614 | 0.050 |
Why?
|
| Transcription, Genetic | 1 | 2008 | 1397 | 0.050 |
Why?
|
| Paraffin Embedding | 1 | 2023 | 41 | 0.050 |
Why?
|
| Formaldehyde | 1 | 2023 | 40 | 0.050 |
Why?
|
| Tissue Fixation | 1 | 2023 | 38 | 0.050 |
Why?
|
| Pilot Projects | 1 | 2007 | 1450 | 0.050 |
Why?
|
| Mentha piperita | 1 | 2022 | 12 | 0.050 |
Why?
|
| Relaxin | 1 | 2002 | 15 | 0.050 |
Why?
|
| Prebiotics | 1 | 2022 | 27 | 0.050 |
Why?
|
| Blotting, Northern | 1 | 2002 | 236 | 0.050 |
Why?
|
| Brain Chemistry | 1 | 2002 | 111 | 0.050 |
Why?
|
| Folic Acid | 1 | 2004 | 288 | 0.040 |
Why?
|
| DNA Primers | 1 | 2002 | 609 | 0.040 |
Why?
|
| Gene Deletion | 3 | 2012 | 773 | 0.040 |
Why?
|
| Cohort Studies | 2 | 2023 | 5120 | 0.040 |
Why?
|
| Retrospective Studies | 4 | 2024 | 17648 | 0.040 |
Why?
|
| Cloning, Molecular | 1 | 2002 | 785 | 0.040 |
Why?
|
| Amino Acid Substitution | 1 | 2002 | 410 | 0.040 |
Why?
|
| Repressor Proteins | 2 | 2002 | 777 | 0.040 |
Why?
|
| Stress, Psychological | 1 | 1986 | 562 | 0.040 |
Why?
|
| Powders | 1 | 2020 | 26 | 0.040 |
Why?
|
| Tumor Burden | 2 | 2012 | 239 | 0.040 |
Why?
|
| Eye | 1 | 2002 | 227 | 0.040 |
Why?
|
| DNA | 2 | 2023 | 1442 | 0.040 |
Why?
|
| Jews | 1 | 2020 | 33 | 0.040 |
Why?
|
| Postmenopause | 1 | 2020 | 149 | 0.040 |
Why?
|
| Cell Line, Tumor | 1 | 2007 | 3672 | 0.040 |
Why?
|
| Research Design | 1 | 2024 | 722 | 0.040 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2023 | 502 | 0.040 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2003 | 634 | 0.040 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2004 | 530 | 0.040 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2025 | 1276 | 0.040 |
Why?
|
| Cost-Benefit Analysis | 1 | 2001 | 543 | 0.040 |
Why?
|
| Dietary Supplements | 1 | 2022 | 453 | 0.040 |
Why?
|
| Black Sea | 1 | 2018 | 1 | 0.040 |
Why?
|
| Gene Ontology | 1 | 2018 | 53 | 0.040 |
Why?
|
| Epigenesis, Genetic | 1 | 2023 | 749 | 0.040 |
Why?
|
| RNA-Binding Proteins | 1 | 2022 | 549 | 0.040 |
Why?
|
| Carrier Proteins | 1 | 2003 | 1024 | 0.030 |
Why?
|
| Tumor Microenvironment | 1 | 2023 | 704 | 0.030 |
Why?
|
| Databases, Genetic | 1 | 2020 | 500 | 0.030 |
Why?
|
| Young Adult | 3 | 2018 | 10092 | 0.030 |
Why?
|
| Nuclear Proteins | 1 | 2003 | 1226 | 0.030 |
Why?
|
| Coronary Disease | 1 | 2020 | 638 | 0.030 |
Why?
|
| Escherichia coli | 1 | 2022 | 984 | 0.030 |
Why?
|
| RNA, Messenger | 1 | 2002 | 2567 | 0.030 |
Why?
|
| Pedigree | 1 | 2020 | 1710 | 0.030 |
Why?
|
| HapMap Project | 1 | 2016 | 13 | 0.030 |
Why?
|
| Gene Regulatory Networks | 1 | 2018 | 380 | 0.030 |
Why?
|
| Transgenes | 2 | 2010 | 323 | 0.030 |
Why?
|
| Neoplasm Grading | 1 | 2016 | 275 | 0.030 |
Why?
|
| Pathology, Molecular | 1 | 2015 | 63 | 0.030 |
Why?
|
| Age Distribution | 1 | 2016 | 429 | 0.030 |
Why?
|
| DNA, Neoplasm | 1 | 2015 | 286 | 0.030 |
Why?
|
| Bayes Theorem | 1 | 2016 | 306 | 0.030 |
Why?
|
| Biomarkers | 1 | 2023 | 3403 | 0.030 |
Why?
|
| Chromosome Banding | 2 | 1991 | 136 | 0.030 |
Why?
|
| Administration, Oral | 1 | 2016 | 705 | 0.030 |
Why?
|
| Probability | 1 | 2013 | 310 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2013 | 320 | 0.020 |
Why?
|
| DNA, Complementary | 1 | 2013 | 436 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2002 | 4762 | 0.020 |
Why?
|
| Texas | 2 | 2012 | 3614 | 0.020 |
Why?
|
| Hemorrhage | 1 | 2016 | 498 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2016 | 1634 | 0.020 |
Why?
|
| Regression Analysis | 1 | 1993 | 773 | 0.020 |
Why?
|
| Urinary Tract Infections | 1 | 2016 | 328 | 0.020 |
Why?
|
| Sperm Count | 1 | 2012 | 92 | 0.020 |
Why?
|
| Airway Remodeling | 1 | 2011 | 22 | 0.020 |
Why?
|
| Nuclear Receptor Subfamily 4, Group A, Member 1 | 1 | 2011 | 33 | 0.020 |
Why?
|
| Muscle, Smooth | 1 | 2012 | 129 | 0.020 |
Why?
|
| Activin Receptors, Type I | 1 | 2011 | 34 | 0.020 |
Why?
|
| Patient Safety | 1 | 2016 | 444 | 0.020 |
Why?
|
| Tissue Distribution | 2 | 2002 | 366 | 0.020 |
Why?
|
| Age of Onset | 1 | 2012 | 631 | 0.020 |
Why?
|
| Organ Size | 1 | 2012 | 434 | 0.020 |
Why?
|
| Muscle Development | 1 | 2010 | 68 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 2 | 2002 | 723 | 0.020 |
Why?
|
| Adolescent | 3 | 2018 | 20918 | 0.020 |
Why?
|
| Quality Improvement | 1 | 2016 | 706 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2015 | 934 | 0.020 |
Why?
|
| Actins | 1 | 2012 | 317 | 0.020 |
Why?
|
| Genes | 1 | 2010 | 308 | 0.020 |
Why?
|
| Age Factors | 1 | 2016 | 2870 | 0.020 |
Why?
|
| Staining and Labeling | 1 | 1990 | 171 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2012 | 1487 | 0.020 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2010 | 239 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 2011 | 803 | 0.020 |
Why?
|
| Apoptosis | 1 | 2016 | 1861 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2016 | 2462 | 0.020 |
Why?
|
| Infertility, Male | 1 | 2012 | 297 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2010 | 665 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2010 | 809 | 0.020 |
Why?
|
| Amino Acid Sequence | 2 | 2002 | 2562 | 0.020 |
Why?
|
| Cysteine Endopeptidases | 1 | 2008 | 113 | 0.020 |
Why?
|
| Heart Failure | 1 | 2020 | 2306 | 0.020 |
Why?
|
| Genetic Linkage | 1 | 2008 | 472 | 0.020 |
Why?
|
| 11-Hydroxycorticosteroids | 1 | 1986 | 1 | 0.020 |
Why?
|
| Testosterone | 1 | 2012 | 603 | 0.020 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2010 | 1005 | 0.020 |
Why?
|
| Mice, Inbred Strains | 1 | 1986 | 297 | 0.010 |
Why?
|
| Models, Biological | 1 | 2010 | 1390 | 0.010 |
Why?
|
| Aneuploidy | 1 | 1986 | 141 | 0.010 |
Why?
|
| Muscle, Skeletal | 1 | 2012 | 990 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2018 | 8589 | 0.010 |
Why?
|
| Registries | 1 | 2012 | 1599 | 0.010 |
Why?
|
| Base Sequence | 1 | 2007 | 2782 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2012 | 5277 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2010 | 1944 | 0.010 |
Why?
|
| 3T3 Cells | 1 | 2002 | 120 | 0.010 |
Why?
|
| Infant | 1 | 2018 | 13300 | 0.010 |
Why?
|
| Luciferases | 1 | 2002 | 127 | 0.010 |
Why?
|
| Urinary Bladder | 1 | 2004 | 249 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2002 | 260 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2018 | 15047 | 0.010 |
Why?
|
| Glycine | 1 | 2002 | 165 | 0.010 |
Why?
|
| Plasmids | 1 | 2002 | 455 | 0.010 |
Why?
|
| Contig Mapping | 1 | 2001 | 51 | 0.010 |
Why?
|
| Pigmentation | 1 | 2001 | 35 | 0.010 |
Why?
|
| Genetic Testing | 1 | 2008 | 1098 | 0.010 |
Why?
|
| Transcriptional Activation | 1 | 2002 | 414 | 0.010 |
Why?
|
| Transfection | 1 | 2002 | 960 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2002 | 1018 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2001 | 624 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2016 | 12937 | 0.010 |
Why?
|
| Infertility | 1 | 2001 | 79 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 2002 | 567 | 0.010 |
Why?
|
| Spermatogenesis | 1 | 2001 | 171 | 0.010 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2001 | 755 | 0.010 |
Why?
|
| Peptides | 1 | 2002 | 835 | 0.010 |
Why?
|
| Protein Binding | 1 | 2002 | 1710 | 0.010 |
Why?
|
| Child | 1 | 2018 | 26240 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2001 | 4683 | 0.010 |
Why?
|
| Siberia | 1 | 1988 | 5 | 0.000 |
Why?
|
| Animals, Wild | 1 | 1988 | 30 | 0.000 |
Why?
|